期刊文献+

肿瘤坏死因子-α基因-308多态性与同种异体肝脏移植急性排斥反应的Meta分析

A Meta-analysis of TNF-αgene-308 Polymorphism in the Risks of Renal Allograft Hepatic Rejection
下载PDF
导出
摘要 目的运用Meta分析的方法综合评价肿瘤坏死因子-α基因-308位点基因多态性与同种异体肝脏移植急性排斥反应发生风险的关系。方法检索MEDLINE、EMBASE和中国生物医学文献数据库(中文),纳入符合质量评价要求、涉及肿瘤坏死因子-α基因-308位点基因多态性与同种异体肝脏移植急性排斥反应关联的队列研究和病例对照研究。应用RevMan4.2软件进行统计分析。结果8个关于西方人群的研究结果表明:肿瘤坏死因子-α基因-308位点高分泌基因型患者肝脏移植后急性排斥发生率与低分泌基因型患者间差异无统计学意义(OR=1.35,95%CI=0.78~2.35,P=0.28)。结论西方人群肿瘤坏死因子-α基因-308位点高分泌基因型与急性排斥反应间未见明显相关关系,但需增加样本量,提高研究质量进一步研究。 Objective To investigate the association between TNF-α gene-308 polymorphism and hepatic allograft acute rejection using the methods of rneta-analysis. Methods References,involving the association between TNF-α gene-308 polyrnorphisrn and hepatic allograft acute rejection, were retrieved through the computerized MEDLINE, EMBASE, Cochrane and CBM and also meet the needs of quality appraisal. All of the data were analysed using RevMan4.2 software. Results There was no significant difference between the TNF-α gene frequencies of A/A or A/G and the odds of renal allograft acute rejection(OR=1.35, 95%CI=0.78-2.35,P=0.28). Conclusion The rneta-analysis suggests the TNF-α gene-308 polyrnorphisrn might have no relation to hepatic allograft acute rejection, but we must further identify it by big sample size and high quality studies.
作者 张巍 温浩
出处 《循证医学》 CSCD 2006年第3期154-157,共4页 The Journal of Evidence-Based Medicine
关键词 肿瘤坏死因子-Α 肝移植 急性排斥反应 META分析 tumor necrosis factor α(TNF-α) liver transplantation acute rejection rneta-analysis
  • 相关文献

参考文献11

  • 1Imagawa DK, Minis JM, Ohhoff KM,et al. The role of tumor necrosis factor in allograft rejection [J]. Transplantation, 1990,50:219-225.
  • 2Maury CPJ, Teppo AM. Raised serum levels of tumor necrosis factor-alpha in renal allograft rejection [J]. J Exp Med, 1987,166: 1132-1137.
  • 3Cunningham DA, Dunn M J, Yacoub MH, et al. Local production of cytokines in the human cardiax allograft [J].Transplantation, 1994,57: 1333-1339.
  • 4Fernandes H, Koneru B, Fernandes N, et al. Investigation of promoter polymorphisms in the tumor necrosis factor-α and interleukin-10 genes in liver transplant petients [J].Transplantation, 2002,73(12): 1886-1891.
  • 5Bathgate AJ, Pravica V, Perrey C, et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10,and transforming growth factor-beta l genes in acute hepatic allograft rejection [J]. Transplantation, 2000,69 (7): 1514-1517.
  • 6Tambur AR, Ortegel JW, Ben-Ari Z, et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients [J]. Transplantation,2001, 71(10): 1475-1480.
  • 7Jonsson JR, Hong C, Purdie DM, et al. Role of cytokine gene polymorphism in acute rejection and renal impairment after liver transplantation [J]. Liver Transplantation,2001,7 (3):255-263.
  • 8Jazrawi SF, Zaman A, Muhammad Z, et al. Tumor nacrosis factor-α promoter polymorphisms and the risk of rejection after liver transplantation:A case control analysis of 210 donor-recipient pairs [J]. Liver Transplantation, 2003,9 (4):377-382.
  • 9Warle MC, Farhan A, Metselaar HI, et al. Cytokine gene polymorphisms and acute human liver graft rejection[J]. Liver Transplantation, 2002,8(7): 603-611.
  • 10Mas VR, Fisher RA, Maluf DG, et al. Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation[J]. Clin Genet, 2004,65: 191-201.

二级参考文献12

  • 1Freeman RBJ;Tran CL;Mattoli J.Tumor necrosis factor genetic polymo rphisms correlate with infections after liver transplantation[J],1999(7).
  • 2Jordan SC;Czer L;Toyoda M.Serum cytokine levels in heart allograft recipients:correlation with findings on end-myocardial biopsy,1993(12).
  • 3Rolfe MW;Kunkle S;Lincoln P.Lung allograft rejection role of tumor necrosis factor-alpha and interleukin-6[J],1993.
  • 4Dorge SE;Roux Lomard P;Dayer JM.Plasma levels of tumor necrosis factor and soluble TNF receptors in kidney transplant recipients[J],1994.
  • 5Noguchi K;YoshidaY;Yagihashi A.Serum levels of interleukin-6,tumor necrosis factor-alpha,and interleukin-2 in rejection of human small bowel allografts,1992.
  • 6Gerwal H;Kotb M;Salem A.Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection,1993.
  • 7Hoffman MW;Wonigei K;Steinhoff G.Production of cytokines(TNF-alpha,IL-1beta) and endothelial cell activatiion in human liver allograft rejection,1993.
  • 8Wilson AG;Symons JA;McDowell TL.Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation,1997.
  • 9Bathgate AJ;Pravica V;Perrey C.The effect of polymorphisms in tumor necrosis factor-alpha,interleukin-10,and transforming growth factor-beta gene in acute hepatic allograft rejection[J],2000.
  • 10Rosen HR;Lentz JJ;Rose SL.Donor polymorphism of tumor necrosis factor gene:relationship with variable severity of hepatitis C recurrence after liver transplantation,2000.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部